Literature DB >> 2875407

Potential ganglioside antigens associated with human gliomas.

P Fredman, H von Holst, V P Collins, A Ammar, B Dellheden, B Wahren, L Granholm, L Svennerholm.   

Abstract

Gangliosides in human gliomas were investigated and found to have an altered composition and concentration as compared to normal grey and white matter of brain. The major gangliosides GM1, GD1a, and GT1b were markedly reduced in the tumour tissue and in contrast there was an increase of gangliosides GM3 and GD3, which often appeared as the dominating ones. Moreover, the tumours contained gangliosides, both mono- and oligosialylated, which could not be detected in the normal brain. The concentration of gangliosides, 0.7 +/- 0.4 mumol sialic acid/g, was significantly lower as compared to normal brain grey (p less than 0.001) and white matter (p less than 0.01), which contained 3.5 +/- 0.3 and 1.2 +/- 0.3 mumol sialic acid/g respectively. The tumour tissue concentration of phospholipids was 14 +/- 8 and of cholesterol 19 +/- 12 mumol/g. The appearance in glioma tissue of gangliosides that are not found in normal brain tissue suggests that these are tumour associated and might serve as surface antigens detectable by specific monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875407     DOI: 10.1080/01616412.1986.11739744

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  11 in total

1.  ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway.

Authors:  Khoa Nguyen; Yuanqing Yan; Bin Yuan; Abhishek Dasgupta; Jeffrey Sun; Hong Mu; Kim-Anh Do; Naoto T Ueno; Michael Andreeff; V Lokesh Battula
Journal:  Mol Cancer Ther       Date:  2018-09-20       Impact factor: 6.261

2.  Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro.

Authors:  K M Hedberg; B Dellheden; C J Wikstrand; P Fredman
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

3.  GD3 expression by cultured human tumor cells of neuroectodermal origin.

Authors:  X He; C J Wikstrand; P Fredman; J E Månsson; L Svennerholm; D D Bigner
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 4.  Signaling domains of cancer-associated glycolipids.

Authors:  Koichi Furukawa; Yuhsuke Ohmi; Kazunori Hamamura; Yuji Kondo; Yuki Ohkawa; Kei Kaneko; Noboru Hashimoto; Farhana Yesmin; Robiul H Bhuiyan; Orie Tajima; Keiko Furukawa
Journal:  Glycoconj J       Date:  2022-03-22       Impact factor: 2.916

5.  Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.

Authors:  Yi-Wei Lou; Pao-Yuan Wang; Shih-Chi Yeh; Po-Kai Chuang; Shiou-Ting Li; Chung-Yi Wu; Kay-Hooi Khoo; Michael Hsiao; Tsui-Ling Hsu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

6.  An improved method for the measurement of total lipid-bound sialic acids after cleavage of alpha 2,8 sialic acid linkage with Vibrio cholerae sialidase in the presence of cholic acid, SDS and Ca2+.

Authors:  M A Maliakal; M H Ravindranath; R F Irie; D L Morton
Journal:  Glycoconj J       Date:  1994-04       Impact factor: 2.916

7.  Expression of the GM1-species, [NeuN]-GM1, in a case of human glioma.

Authors:  P Fredman; J E Månsson; B Dellheden; K Boström; H von Holst
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

8.  Assessment of total sialic acid and lipid-bound sialic acid in management of brain tumors.

Authors:  Manjula Shantaram; Anjali Rao; Annaya Rao Aroor; Annaswamy Raja; Suryanrayana Rao; Flama Monteiro
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

9.  Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.

Authors:  D C Longee; C J Wikstrand; J E Månsson; X He; G N Fuller; S H Bigner; P Fredman; L Svennerholm; D D Bigner
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Imaging mass spectrometry identifies prognostic ganglioside species in rodent intracranial transplants of glioma and medulloblastoma.

Authors:  Leonardo Ermini; Elena Morganti; Alexander Post; Behzad Yeganeh; Isabella Caniggia; Michael Leadley; Claudia C Faria; James T Rutka; Martin Post
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.